Laddis T, Manning W J, Danias P G
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
J Nucl Cardiol. 2001 Mar-Apr;8(2):207-14. doi: 10.1067/mnc.2001.112539.
Cardiac magnetic resonance imaging (MRI) has recently been applied successfully to the assessment of myocardial perfusion. Cardiac MRI offers potential advantages over radioisotopic techniques because it provides superior spatial resolution, does not use ionizing radiation, and has no imaging orientation constraints. Current MRI perfusion approaches measure the alteration of regional myocardial magnetic properties after the intravenous injection of contrast agents. Several studies have validated the ability of perfusion MRI to detect the presence of significant coronary artery stenoses by detecting decreased signal intensity upslope or reduced maximal enhancement in the ischemic territories. Perfusion MRI has also been shown to assess accurately the extent of injury after a myocardial infarction and the presence of myocardial viability. With the introduction of newer contrast media, technologic improvements on MRI hardware and software, and the enhancement of quantitative analysis, MRI is likely to become a clinical tool for assessment of myocardial perfusion imaging in the near future.
心脏磁共振成像(MRI)最近已成功应用于心肌灌注评估。心脏MRI相对于放射性同位素技术具有潜在优势,因为它提供了更高的空间分辨率,不使用电离辐射,并且没有成像方向限制。当前的MRI灌注方法是在静脉注射造影剂后测量局部心肌磁性特性的变化。多项研究已证实,灌注MRI能够通过检测缺血区域信号强度上升斜率降低或最大强化减弱来检测显著冠状动脉狭窄的存在。灌注MRI还被证明能够准确评估心肌梗死后的损伤范围以及心肌存活情况。随着更新的造影剂的引入、MRI硬件和软件的技术改进以及定量分析的增强,MRI在不久的将来可能会成为评估心肌灌注成像的临床工具。